Velagliflozin (Senvelgo) side effects in cats
4,798 reports sent to the FDA between 2023 and 2026 involve Velagliflozin in cats. The most reported problems were ketosis, weight loss, loss of appetite. 16% were marked serious, and where it was recorded, signs eased after stopping the medicine in 91% of cases.
About this medicine
Velagliflozin treats diabetes in cats (oral, an SGLT2 inhibitor).
Products with this ingredient include Senvelgo. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
Most reported side effects
Share = percentage of this medicine's reports that mention the problem. One report can list several problems.
Reports that it didn't work
Some reports are about the medicine not working (for example a cat still getting fleas or heartworm), not about a side effect.
How soon problems started
Time from the first dose to the first sign, where both dates were reported (4,421 reports).
How the animals did
Breeds named most often
Popular breeds appear more often because there are more of them.
- Domestic Shorthair 3,285 reports
- Domestic Longhair 421 reports
- Domestic Mediumhair 277 reports
- Siamese 61 reports
- Maine Coon 46 reports
- Russian 24 reports
- Ragdoll 21 reports
- Persian 18 reports
- Sphynx 17 reports
- Cat (other) 15 reports